HMGCR anticorps (AA 629-888)

N° du produit ABIN3022294

Détail du produit anti-HMGCR anticorps

Antigène: HMGCR (3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR))

Épitope: AA 629-888

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp HMGCR est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Séquence: ARLQKLHTSI AGRNLYIRFQ SRSGDAMGMN MISKGTEKAL SKLHEYFPEM QILAVSGNYC TDKKPAAINW IEGRGKSVVC EAVIPAKVVR EVLKTTTEAM IEVNINKNLV GSAMAGSIGG YNAHAANIVT AIYIACGQDA AQNVGSSNCI TLMEASGPTN EDLYISCTMP SIEIGTVGGG TNLLPQQACL QMLGVQGACK DNPGENARQL ARIVCGTVMA GELSLMAALA AGHLVKSHMI HNRSKINLQD LQGACTKKTA

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 629-888 of human HMGCR (NP_000850.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:1000 - 1:4000,IHC,1:50 - 1:100,IF,1:50 - 1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid freeze / thaw cycles

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Références pour anticorps anti-HMGCR (ABIN3022294)

Cheng, Zhu, Han, Zhang, Cui, Shen, Zhang, Yan, Prochownik, Li: "MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice." dans: Cell death & disease, Vol. 8, Issue 7, pp. e2916, (2018) (PubMed).

Li, Xia, Xiong, Wang, Yan: "Effects of sepsis on the metabolism of sphingomyelin and cholesterol in mice with liver dysfunction." dans: Experimental and therapeutic medicine, Vol. 14, Issue 6, pp. 5635-5640, (2017) (PubMed).

Détails sur HMGCR

Antigène: HMGCR (3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR))

Autre désignation: HMGCR (HMGCR Produits)

Synonymes: anticorps HMGR, anticorps LDLCQ3, anticorps hmg-coa-r, anticorps HMG-CoAR, anticorps Red, anticorps 3H3M, anticorps BcDNA:LD15354, anticorps CG10367, anticorps Clb, anticorps DmHMG-CoAr, anticorps Dmel\\CG10367, anticorps HMGCR, anticorps HMGCR_Dm, anticorps HMGCoAR, anticorps HMGCoARr, anticorps HMGCoAr, anticorps HmG-CoAR, anticorps Hmg, anticorps bro1, anticorps bs32f05.y1, anticorps clb, anticorps hmgc, anticorps hmgcr, anticorps hmgrc, anticorps l(3)01152, anticorps l(3)04684, anticorps hmgcr2, anticorps im:6912716, anticorps zgc:110746, anticorps 3-hydroxy-3-methylglutaryl-CoA reductase, anticorps 3-hydroxy-3-methylglutaryl-CoA reductase L homeolog, anticorps 3-hydroxy-3-methylglutaryl-Coenzyme A reductase, anticorps HMG Coenzyme A reductase, anticorps 3-hydroxy-3-methylglutaryl-CoA reductase b, anticorps HMGCR, anticorps hmgcr.L, anticorps Hmgcr, anticorps hmgcrb

Sujet: HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.,HMGCR,LDLCQ3,HMGCR,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Cholesterol Metabolism,AMPK Signaling Pathway,Cardiovascular,Heart,Lipids,Cardiovascular diseases,Heart disease,HMGCR

Poids moléculaire: 92 kDa/97 kDa/99 kDa

ID gène: 3156

UniProt: P04035

Pathways: AMPK Signaling, Negative Regulation of Hormone Secretion, Regulation of Lipid Metabolism by PPARalpha